84,403 Shares in Sotera Health (NASDAQ:SHC) Acquired by Walleye Capital LLC

Walleye Capital LLC acquired a new stake in shares of Sotera Health (NASDAQ:SHC - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 84,403 shares of the company's stock, valued at approximately $1,410,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. William Blair Investment Management LLC lifted its stake in shares of Sotera Health by 0.6% in the 2nd quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company's stock worth $13,430,000 after purchasing an additional 6,707 shares during the period. Clearline Capital LP bought a new position in Sotera Health in the second quarter worth approximately $1,707,000. First Pacific Advisors LP bought a new position in Sotera Health in the second quarter worth approximately $540,000. Darsana Capital Partners LP purchased a new position in shares of Sotera Health during the 2nd quarter worth $29,074,000. Finally, Bank of New York Mellon Corp grew its position in shares of Sotera Health by 3.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company's stock valued at $11,918,000 after acquiring an additional 37,681 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Price Performance

SHC traded up $0.16 during trading on Friday, reaching $13.13. The company's stock had a trading volume of 988,391 shares, compared to its average volume of 1,343,911. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The company has a market cap of $3.72 billion, a price-to-earnings ratio of 52.52 and a beta of 1.96. The firm has a fifty day simple moving average of $14.96 and a two-hundred day simple moving average of $14.06. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same quarter last year, the business posted $0.18 EPS. The firm's revenue for the quarter was up 8.5% on a year-over-year basis. As a group, analysts anticipate that Sotera Health will post 0.61 EPS for the current year.

Analyst Ratings Changes

A number of research analysts recently weighed in on SHC shares. Royal Bank of Canada restated an "outperform" rating and set a $17.00 target price on shares of Sotera Health in a research note on Thursday, November 21st. Citigroup increased their target price on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, November 6th. Finally, The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday. They set a "neutral" rating and a $14.00 price objective for the company. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Sotera Health currently has an average rating of "Moderate Buy" and a consensus price target of $16.08.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.